Jun
2026
Pennsylvania Convention Center, Philadelphia
Visit us
stand 1205
Zone

Nanjing Hanxin Pharmaceutical Co.,Ltd

Exhibitor at CPHI Americas 2026
About Us

About Us Founded on July 6, 2021, through the restructuring of Amphastar Pharmaceuticals, Inc. (USA) China R&D Center, Nanjing Hanxin Pharmaceuticals Co., Ltd. has a registered capital of CNY 183 million. Leveraging advanced technology platforms and strong R&D capabilities, Hanxin has emerged as a global pharmaceutical Company- engaged in the research, manufacture, and sales of peptides, proteins, and polysaccharides (APIs and finished dosage forms).

  • Country/Region:
    China
  • On CPHI since:
    2024
  • Employees:
    250 - 499
Company types
Biopharmaceutical company
CMO/CDMO
Machinery and Equipment Supplier/Manufacturer
Contact info
  • Building C5 , No.9 Weidi Road,, Xianlin University Town, Xianlin Street,Qixia, Nanjing, Jiangsu, China
Event information
CPHI Americas 2026
  • 2 Jun 2026 - 4 June 2026
  • Pennsylvania Convention Center, Philadelphia
  • Visit us at stand 1205